Eastwood Bio Medical Canada Stock Analysis

Eastwood Stock Analysis Notes

About 70.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.01. Eastwood Bio Medical had not issued any dividends in recent years. Eastwood Bio-Medical Canada Inc. researches and develops natural health products in North America and Asia. Eastwood Bio-Medical Canada Inc. is a subsidiary of Eastwood Bio-Medical Research Inc. EASTWOOD BIO operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange. To learn more about Eastwood Bio Medical Canada call Youngsoo Kim at 604 247 2100 or check out https://www.eleotin.ca.

Eastwood Bio Medical Investment Alerts

Eastwood Bio-Medical Thematic Classifications

Eastwood Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 51.66 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Eastwood Bio-Medical's market, we take the total number of its shares issued and multiply it by Eastwood Bio-Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Eastwood Profitablity

The company has Profit Margin (PM) of (0.74) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.51) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.51.

Management Efficiency

Eastwood Bio Medical has return on total asset (ROA) of (0.6415) % which means that it has lost $0.6415 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (7.4716) %, meaning that it generated substantial loss on money invested by shareholders. Eastwood Bio-Medical's management efficiency ratios could be used to measure how well Eastwood Bio-Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to climb to 0.85 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (1.22). At this time, Eastwood Bio-Medical's Non Current Assets Total are fairly stable compared to the past year. Asset Turnover is likely to climb to 1.21 in 2024, whereas Total Assets are likely to drop slightly above 418.2 K in 2024.

Technical Drivers

As of the 29th of November, Eastwood Bio-Medical shows the Mean Deviation of 10.78, downside deviation of 20.35, and Coefficient Of Variation of 972.15. Eastwood Bio Medical technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Eastwood Bio Medical variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and semi variance to decide if Eastwood Bio Medical is priced favorably, providing market reflects its regular price of 0.75 per share.

Eastwood Bio Medical Price Movement Analysis

Eastwood Bio-Medical Outstanding Bonds

Eastwood Bio-Medical Predictive Daily Indicators

Eastwood Bio-Medical Forecast Models

Eastwood Bio-Medical's time-series forecasting models are one of many Eastwood Bio-Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Eastwood Bio-Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Eastwood Bio-Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Eastwood shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Eastwood Bio-Medical. By using and applying Eastwood Stock analysis, traders can create a robust methodology for identifying Eastwood entry and exit points for their positions.

When running Eastwood Bio-Medical's price analysis, check to measure Eastwood Bio-Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio-Medical is operating at the current time. Most of Eastwood Bio-Medical's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio-Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio-Medical's price. Additionally, you may evaluate how the addition of Eastwood Bio-Medical to your portfolios can decrease your overall portfolio volatility.